Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. II. Biological activity of the enzyme.
作者信息
GADEBUSCH H H
出版信息
J Infect Dis. 1960 Nov-Dec;107:402-5. doi: 10.1093/infdis/107.3.402.
PMID:13702837
Abstract
摘要
相似文献
1
Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. II. Biological activity of the enzyme.
J Infect Dis. 1960 Nov-Dec;107:402-5. doi: 10.1093/infdis/107.3.402.
2
Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. III. Antibody stimulation by partially decapsulated cells.
J Infect Dis. 1960 Nov-Dec;107:406-9. doi: 10.1093/infdis/107.3.406.
3
Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. I. Isolation, partial purification, and properties of the enzyme.
Can J Microbiol. 1961 Feb;7:53-60. doi: 10.1139/m61-007.
4
The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide.
J Immunol. 1951 Aug;67(2):109-14.
5
Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Carbohydr Res. 2004 Feb 25;339(3):503-9. doi: 10.1016/j.carres.2003.11.015.
6
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
J Immunol. 1965 Jun;94:916-20.
7
A consensus structural motif for the capsular polysaccharide of by NMR/MD.
Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2322413121. doi: 10.1073/pnas.2322413121. Epub 2024 Feb 9.
8
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo.
Infect Immun. 2005 Dec;73(12):8429-32. doi: 10.1128/IAI.73.12.8429-8432.2005.
9
Comparison of enzyme immunoassay and latex agglutination methods for detection of Cryptococcus neoformans antigen.
Am J Clin Pathol. 1980 Jun;73(6):790-4. doi: 10.1093/ajcp/73.6.790.
10
Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation.
Clin Vaccine Immunol. 2006 Jul;13(7):740-6. doi: 10.1128/CVI.00139-06.
引用本文的文献
1
Treatment of experimental anthrax with recombinant capsule depolymerase.
Antimicrob Agents Chemother. 2008 Mar;52(3):1014-20. doi: 10.1128/AAC.00741-07. Epub 2007 Dec 26.
2
PREPARATION AND PROPERTIES OF A VI ANTIGEN-DEGRADING ENZYME.
J Bacteriol. 1965 May;89(5):1217-24. doi: 10.1128/jb.89.5.1217-1224.1965.
Zotero 插件